Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
The safety of exercise training in multiple sclerosis: A systematic review.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Minocin
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Transverse myelitis.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Low dose naltrexone therapy in multiple sclerosis.
The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Pages